Archive for the ‘Health Insurance / Medical Insurance’ Category

Fewer children outgrowing allergies to milk, eggs - BabyCenter (Test For Food Allergies)

Saturday, February 16th, 2008

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

Fewer children outgrowing allergies to milk, eggs Wed, Dec 26, 2007 (HealthDay News) Childhood milk and egg allergies may be more persistent and harder to outgrow than they

PCRM >> News and Media Center >> Nutrition Experts Tell Top U.S
In January, PCRM unveiled a new educational campaign ( www.StrongBones.org ) to dispel dairy industry myths about how much calcium children need as well as milk’s ability to

(more…)

DNA from Cloned Animals

Friday, February 15th, 2008

(Ivanhoe Newswire)  Now that the FDA has declared meat and milk from cloned animals is safe to eat, a number of companies are producing cloned animals for the livestock industry.  Some are already marketing semen from clones.

A poll done by Consumers Union found that 89 percent of consumers want their food labeled to indicate whether it’s from cloned animals.   But should access to DNA from every unique clone be made public?  Patrick Cunningham of Dublin’s Trinity College and Chief Scientific Advisor to the Government of Ireland thinks so. 

(more…)

Back Pain Prevention Comes up Short

Wednesday, February 6th, 2008

(Ivanhoe Newswire) — Employers who offer special training and other measures to help employees avoid back pain due to lifting heavy objects may be wasting their money.

Finnish researchers who reviewed the results of 11 studies comparing back pain prevention interventions with each other and with no intervention at all find little difference in outcomes between the groups.

The studies included eight trials involving health care workers who were charged with moving patients and three trials involving workers in the baggage handling and postal industries. The studies looked at things like training programs to teach people to lift correctly, the use of back belts to support the back during lifting, physical exercise to keep the back in better shape, and several combinations of these measures. Some of the studies compared people who received some kind of intervention with those who received no help at all.

(more…)

President Signs Prescription Drug Safety Bill

Friday, December 21st, 2007

President Bush today signed a comprehensive Food and Drug Administration bill that focuses on prescription drug safety reforms. The bill holds the prescription drug industry more accountable for the safety of their products by requiring them to publicly disclose drug safety studies, even the ones that show their medicines in an unflattering light. It also increases the budget for drug safety reviews at the Food and Drug Administration.

Statement by CALPIRG Advocate Emily Rusch:

(more…)

Prescription Drug Safety Measure Clears Assembly Committee

Friday, December 21st, 2007

California bill will prod national decision makers, serve in lieu of federal policy if Congress fails to act

SACRAMENTO—The California Assembly Health Committee passed the Pharmaceutical Drug Information and Safety Act, SB 606 (Scott), today with all members present voting in favor of the bill. The measure will require pharmaceutical companies to disclose the results of clinical studies, meaning that doctors, patients, researchers and even industry competitors will gain access to information on the side effects and effectiveness of medicine currently on the market.

(more…)

Prescription Drug Safety Measure Clears Assembly Committee

Friday, December 21st, 2007

California bill will prod national decision makers, serve in lieu of federal policy if Congress fails to act

SACRAMENTO—The California Assembly Health Committee passed the Pharmaceutical Drug Information and Safety Act, SB 606 (Scott), today with all members present voting in favor of the bill. The measure will require pharmaceutical companies to disclose the results of clinical studies, meaning that doctors, patients, researchers and even industry competitors will gain access to information on the side effects and effectiveness of medicine currently on the market.

(more…)

Consumer Groups Laud Agreement on Prescription Drug Discounts

Friday, December 21st, 2007

Statement of CALPIRG Health Care Advocate Emily Clayton on the prescription drug discount agreement

“CALPIRG is pleased to join a broad coalition of organizations representing consumers, seniors, working families and communities of color in supporting SB 1702 and AB 2911 by Senator Perata and Speaker Nez. This legislation is a crucial step forward in the ongoing fight to bring affordable medicine to all Californians.

“The discounts provided by this legislation will lower the cost of prescription drugs for more than five million low and moderate income uninsured Californians. The plan gives the pharmaceutical industry three years to voluntarily offer meaningful discounts. If they refuse, the state may, just as all large insurers do, use the weight of its purchasing power to induce discounts. The legislation also includes a series of strong consumer protections that ensure no Medi-Cal patient will be denied access to a medically necessary drug.

(more…)

Senate Passes Drug Safety Legislation: Bill Will Protect Patients From Unsafe Medicines

Friday, December 21st, 2007

Washington, DC — In a victory for consumers, the Senate today passed the “Food and Drug Administration Revitalization Act” sponsored by Senator Ted Kennedy (D-Mass.) by a vote of 93 to 1.

The bill attempts to please both the powerful pharmaceutical industry and consumer groups. It increases the amount of money the FDA receives in fees from drug makers to speed the approval of new drugs, and includes language to protect consumers from unsafe prescription drugs.

(more…)

Prescription Drug Safety Bill Stalls In State Senate

Friday, December 21st, 2007

Supporters vow to keep fighting for measure this year

SACRAMENTO—Doctors, patients, consumer groups and health care advocates were dealt a setback by the state Senate this week when it failed to advance the Pharmaceutical Drug Right-to-Know Act. The legislation, SB 1683 by Senator Jack Scott (Altadena), would have required pharmaceutical companies to disclose the results of all their health studies, good and bad. It was introduced in response to the VIOXX tragedy, which was worsened by drug giant Merck's cover-up of its own negative health studies, and other drug safety tragedies like it.

(more…)

ABPI: UK medicines research under threat

Friday, December 21st, 2007


New figures show that the UK boom in medicines research could be under threat, according to the Association of the British Pharmaceutical Industry (ABPI). ABPI figures show that total expenditure on research and development (R&D) on new medicines by the UK-based pharmaceutical industry fell by two per cent in real terms to ?3,244 million in 2004 - unchanged in cash terms from the 2003 figure of ?3,241 million.
(more…)